• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两种螯合剂支架作为靶向胆囊收缩素-2受体的双模态成像探针基础的比较

Comparison of Two Chelator Scaffolds as Basis for Cholecystokinin-2 Receptor Targeting Bimodal Imaging Probes.

作者信息

Gariglio Giacomo, Bendova Katerina, Hermann Martin, Olafsdottir Asta, Sosabowski Jane K, Petrik Milos, von Guggenberg Elisabeth, Decristoforo Clemens

机构信息

Department of Nuclear Medicine, Medical University of Innsbruck, 6020 Innsbruck, Austria.

Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, 77900 Olomouc, Czech Republic.

出版信息

Pharmaceuticals (Basel). 2024 Nov 22;17(12):1569. doi: 10.3390/ph17121569.

DOI:10.3390/ph17121569
PMID:39770411
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11676163/
Abstract

: Dual-modality probes, combining positron emission tomography (PET) with fluorescence imaging (FI) capabilities in a single molecule, are of high relevance for the accurate staging and guided resection of tumours. We herein present a pair of candidates targeting the cholecystokinin-2 receptor (CCK2R), namely [Ga]Ga-CyTMG and [Ga]Ga-CyFMG. In these probes, the SulfoCy5.5 fluorophore and two units of a CCK2R-binding motif are coupled to the chelator acting as a core scaffold, triazacyclononane-phosphinic acid (TRAP), and Fusarinine C (FSC), respectively. Using this approach, we investigated the influence of these chelators on the final properties. : The synthetic strategy to both precursors was based on the stoichiometric conjugation of the components via click chemistry. The characterization in vitro included the evaluation of the CCK2R affinity and internalization in A431-CCK2R cells. Ex vivo biodistribution as well as PET and FI studies were performed in xenografted mice. : Ga labelling was accomplished with high radiochemical yield and purity for both precursors. A CCK2R affinity in the subnanomolar range of the conjugates and a receptor-specific uptake of the radioligands in cells were observed. In A431-CCK2R/A431-mock xenografted mice, the investigated compounds showed specific accumulation in the tumours and reduced off-target uptake compared to a previously developed compound. Higher accumulation and prolonged retention in the kidneys were observed for [Ga]Ga-CyTMG when compared to [Ga]Ga-CyFMG. Despite the promising targeting properties observed, further probe optimization is required to achieve enhanced imaging contrast at early timepoints. Additionally, the results indicate a distinct influence of the chelators in terms of renal accumulation and retention.

摘要

双模态探针将正电子发射断层扫描(PET)与单分子荧光成像(FI)功能相结合,对于肿瘤的准确分期和引导切除具有高度相关性。我们在此展示了一对靶向胆囊收缩素-2受体(CCK2R)的候选物,即[Ga]Ga-CyTMG和[Ga]Ga-CyFMG。在这些探针中,磺基Cy5.5荧光团和两个CCK2R结合基序单元分别与作为核心支架的螯合剂三氮杂环壬烷膦酸(TRAP)和Fusarinine C(FSC)偶联。通过这种方法,我们研究了这些螯合剂对最终性质的影响。

两种前体的合成策略基于通过点击化学对各组分进行化学计量共轭。体外表征包括评估A431-CCK2R细胞中CCK2R的亲和力和内化情况。在异种移植小鼠中进行了体内生物分布以及PET和FI研究。

两种前体的镓标记均以高放射化学产率和纯度完成。观察到缀合物在亚纳摩尔范围内具有CCK2R亲和力,并且放射性配体在细胞中具有受体特异性摄取。在A⁴³¹-CCK₂R/A⁴³¹-对照异种移植小鼠中,与先前开发的化合物相比,所研究的化合物在肿瘤中显示出特异性积累,并且脱靶摄取减少。与[Ga]Ga-CyFMG相比,[Ga]Ga-CyTMG在肾脏中观察到更高的积累和更长时间的滞留。尽管观察到了有前景的靶向特性,但仍需要进一步优化探针以在早期时间点实现增强的成像对比度。此外,结果表明螯合剂在肾脏积累和滞留方面有明显影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e00/11676163/750bfaece3d0/pharmaceuticals-17-01569-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e00/11676163/e53eb962dd87/pharmaceuticals-17-01569-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e00/11676163/0bc3434743b1/pharmaceuticals-17-01569-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e00/11676163/74a57934474f/pharmaceuticals-17-01569-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e00/11676163/fe44e1b467f8/pharmaceuticals-17-01569-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e00/11676163/8de034862294/pharmaceuticals-17-01569-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e00/11676163/b3d3ee749934/pharmaceuticals-17-01569-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e00/11676163/7df8c1f2fd76/pharmaceuticals-17-01569-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e00/11676163/a8e509c13120/pharmaceuticals-17-01569-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e00/11676163/750bfaece3d0/pharmaceuticals-17-01569-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e00/11676163/e53eb962dd87/pharmaceuticals-17-01569-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e00/11676163/0bc3434743b1/pharmaceuticals-17-01569-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e00/11676163/74a57934474f/pharmaceuticals-17-01569-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e00/11676163/fe44e1b467f8/pharmaceuticals-17-01569-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e00/11676163/8de034862294/pharmaceuticals-17-01569-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e00/11676163/b3d3ee749934/pharmaceuticals-17-01569-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e00/11676163/7df8c1f2fd76/pharmaceuticals-17-01569-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e00/11676163/a8e509c13120/pharmaceuticals-17-01569-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e00/11676163/750bfaece3d0/pharmaceuticals-17-01569-g009.jpg

相似文献

1
Comparison of Two Chelator Scaffolds as Basis for Cholecystokinin-2 Receptor Targeting Bimodal Imaging Probes.两种螯合剂支架作为靶向胆囊收缩素-2受体的双模态成像探针基础的比较
Pharmaceuticals (Basel). 2024 Nov 22;17(12):1569. doi: 10.3390/ph17121569.
2
Exploiting the Concept of Multivalency with Ga- and Zr-Labelled Fusarinine C-Minigastrin Bioconjugates for Targeting CCK2R Expression.利用 Ga 和 Zr 标记的 Fusarinine C-Minigastrin 生物缀合物的多价性来靶向 CCK2R 表达。
Contrast Media Mol Imaging. 2018 Apr 10;2018:3171794. doi: 10.1155/2018/3171794. eCollection 2018.
3
Developing Targeted Hybrid Imaging Probes by Chelator Scaffolding.通过螯合剂支架开发靶向混合成像探针。
Bioconjug Chem. 2017 Jun 21;28(6):1722-1733. doi: 10.1021/acs.bioconjchem.7b00182. Epub 2017 May 10.
4
DOTA-MGS5, a New Cholecystokinin-2 Receptor-Targeting Peptide Analog with an Optimized Targeting Profile for Theranostic Use.DOTA-MGS5,一种新型胆囊收缩素 2 受体靶向肽类似物,具有优化的治疗诊断用途靶向谱。
J Nucl Med. 2019 Jul;60(7):1010-1016. doi: 10.2967/jnumed.118.221283. Epub 2018 Dec 7.
5
Multimerization results in formation of re-bindable metabolites: A proof of concept study with FSC-based minigastrin imaging probes targeting CCK2R expression.多聚化导致可再结合代谢物的形成:以基于 FSC 的 minigastrin 成像探针靶向 CCK2R 表达为研究对象的概念验证研究。
PLoS One. 2018 Jul 30;13(7):e0201224. doi: 10.1371/journal.pone.0201224. eCollection 2018.
6
Automated Synthesis of Ga-Labeled DOTA-MGS8 and Preclinical Characterization of Cholecystokinin-2 Receptor Targeting.自动化合成 Ga 标记的 DOTA-MGS8 及其胆囊收缩素 2 受体靶向的临床前特征
Molecules. 2022 Mar 21;27(6):2034. doi: 10.3390/molecules27062034.
7
Influence of a novel, versatile bifunctional chelator on theranostic properties of a minigastrin analogue.一种新型多功能双功能螯合剂对小胃泌素类似物诊疗特性的影响。
EJNMMI Res. 2015 Dec;5(1):74. doi: 10.1186/s13550-015-0154-7. Epub 2015 Dec 15.
8
Comparison of Ga-68-Labeled Fusarinine C-Based Multivalent RGD Conjugates and [(68)Ga]NODAGA-RGD-In Vivo Imaging Studies in Human Xenograft Tumors.基于68Ga标记的镰刀菌素C的多价RGD缀合物与[(68)Ga]NODAGA-RGD在人异种移植肿瘤体内成像研究的比较。
Mol Imaging Biol. 2016 Oct;18(5):758-67. doi: 10.1007/s11307-016-0931-3.
9
[(68)Ga]FSC-(RGD)3 a trimeric RGD peptide for imaging αvβ3 integrin expression based on a novel siderophore derived chelating scaffold-synthesis and evaluation.[(68)Ga]FSC-(RGD)3:一种基于新型铁载体衍生螯合支架的三聚体RGD肽,用于成像αvβ3整合素表达——合成与评估
Nucl Med Biol. 2015 Feb;42(2):115-22. doi: 10.1016/j.nucmedbio.2014.10.001. Epub 2014 Oct 13.
10
Development of a New Folate-Derived Ga-68-Based PET Imaging Agent.新型叶酸衍生的 Ga-68 基 PET 成像剂的研制。
Mol Imaging Biol. 2017 Oct;19(5):754-761. doi: 10.1007/s11307-017-1049-y.

本文引用的文献

1
Cryo-Fluorescence Tomography as a Tool for Visualizing Whole-Body Inflammation Using Perfluorocarbon Nanoemulsion Tracers.低温荧光断层扫描术:一种使用全氟碳纳米乳剂示踪剂可视化全身炎症的工具。
Mol Imaging Biol. 2024 Oct;26(5):888-898. doi: 10.1007/s11307-024-01926-w. Epub 2024 Jul 17.
2
Effects of Side Chain and Peptide Bond Modifications on the Targeting Properties of Stabilized Minigastrin Analogs.侧链和肽键修饰对稳定化胃泌素类似物靶向特性的影响
Pharmaceuticals (Basel). 2023 Feb 13;16(2):278. doi: 10.3390/ph16020278.
3
Cancer statistics, 2023.
癌症统计数据,2023 年。
CA Cancer J Clin. 2023 Jan;73(1):17-48. doi: 10.3322/caac.21763.
4
Intraoperative Tumor Detection Using Pafolacianine.术中使用帕拉福酰胺检测肿瘤。
Int J Mol Sci. 2022 Oct 25;23(21):12842. doi: 10.3390/ijms232112842.
5
Dual-Labelling Strategies for Nuclear and Fluorescence Molecular Imaging: Current Status and Future Perspectives.用于核与荧光分子成像的双标记策略:现状与未来展望
Pharmaceuticals (Basel). 2022 Mar 31;15(4):432. doi: 10.3390/ph15040432.
6
PET/Fluorescence Imaging: An Overview of the Chemical Strategies to Build Dual Imaging Tools.正电子发射断层扫描/荧光成像:构建双模式成像工具的化学策略概述。
Bioconjug Chem. 2022 Jan 19;33(1):24-52. doi: 10.1021/acs.bioconjchem.1c00503. Epub 2022 Jan 7.
7
Molecular imaging in oncology: Current impact and future directions.肿瘤学中的分子影像学:当前影响和未来方向。
CA Cancer J Clin. 2022 Jul;72(4):333-352. doi: 10.3322/caac.21713. Epub 2021 Dec 13.
8
Update on Preclinical Development and Clinical Translation of Cholecystokinin-2 Receptor Targeting Radiopharmaceuticals.胆囊收缩素-2受体靶向放射性药物的临床前开发与临床转化进展
Cancers (Basel). 2021 Nov 18;13(22):5776. doi: 10.3390/cancers13225776.
9
PET/CT imaging of head-and-neck and pancreatic cancer in humans by targeting the "Cancer Integrin" αvβ6 with Ga-68-Trivehexin.用 Ga-68-三乙烯四胺五乙酸(Trivehexin)靶向“癌症整合素”αvβ6 对人类头颈部和胰腺癌进行 PET/CT 成像。
Eur J Nucl Med Mol Imaging. 2022 Mar;49(4):1136-1147. doi: 10.1007/s00259-021-05559-x. Epub 2021 Sep 24.
10
PET/CT imaging of pancreatic carcinoma targeting the "cancer integrin" αvβ6.靶向“癌症整合素”αvβ6的胰腺癌PET/CT成像
Eur J Nucl Med Mol Imaging. 2021 Nov;48(12):4107-4108. doi: 10.1007/s00259-021-05443-8. Epub 2021 Jun 9.